NZ502684A - Solution phase synthesis of phosphorothioate triesters - Google Patents

Solution phase synthesis of phosphorothioate triesters

Info

Publication number
NZ502684A
NZ502684A NZ502684A NZ50268498A NZ502684A NZ 502684 A NZ502684 A NZ 502684A NZ 502684 A NZ502684 A NZ 502684A NZ 50268498 A NZ50268498 A NZ 50268498A NZ 502684 A NZ502684 A NZ 502684A
Authority
NZ
New Zealand
Prior art keywords
solution phase
phase synthesis
phosphonate
phosphorothioate
phosphorothioate triesters
Prior art date
Application number
NZ502684A
Other languages
English (en)
Inventor
Colin Bernard Reese
Quanlai Song
Original Assignee
Avecia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Avecia Ltd filed Critical Avecia Ltd
Publication of NZ502684A publication Critical patent/NZ502684A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00Processes for the preparation of sugar derivatives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/281,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/301,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • C07D265/321,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings with oxygen atoms directly attached to ring carbon atoms
    • C07D265/33Two oxygen atoms, in positions 3 and 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/46Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with hetero atoms directly attached to the ring nitrogen atom
    • C07D207/48Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/16Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165Esters of thiophosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/16Esters of thiophosphoric acids or thiophosphorous acids
    • C07F9/165Esters of thiophosphoric acids
    • C07F9/18Esters of thiophosphoric acids with hydroxyaryl compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04Phosphates; Phosphites; Polyphosphates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/10Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • C07H19/20Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C07H21/04Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NZ502684A 1997-08-13 1998-08-10 Solution phase synthesis of phosphorothioate triesters NZ502684A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9717158.1A GB9717158D0 (en) 1997-08-13 1997-08-13 Solution synthesis of oligonucleotides and their phosphorothioate analogues
PCT/GB1998/002407 WO1999009041A2 (en) 1997-08-13 1998-08-10 Solution phase synthesis of oligonucleotides

Publications (1)

Publication Number Publication Date
NZ502684A true NZ502684A (en) 2002-12-20

Family

ID=10817430

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ502684A NZ502684A (en) 1997-08-13 1998-08-10 Solution phase synthesis of phosphorothioate triesters

Country Status (21)

Country Link
US (3) US6506894B1 (ref)
EP (2) EP1003758B1 (ref)
JP (1) JP2001515086A (ref)
KR (1) KR20010022840A (ref)
CN (1) CN1231492C (ref)
AT (1) ATE236916T1 (ref)
BR (1) BR9811166A (ref)
CA (1) CA2300874A1 (ref)
DE (1) DE69813243T2 (ref)
DK (1) DK1003758T3 (ref)
EA (1) EA003091B1 (ref)
ES (1) ES2197491T3 (ref)
GB (1) GB9717158D0 (ref)
HU (1) HUP0002684A3 (ref)
IL (1) IL134517A (ref)
IN (1) IN190784B (ref)
NO (1) NO20000690L (ref)
NZ (1) NZ502684A (ref)
PL (1) PL338888A1 (ref)
TR (1) TR200000384T2 (ref)
WO (1) WO1999009041A2 (ref)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9924285D0 (en) * 1999-10-14 1999-12-15 Avecia Ltd Process
GB0004889D0 (en) * 2000-03-01 2000-04-19 Avecia Ltd Synthesis of oligonucleotides
AU2002339175A1 (en) * 2001-11-21 2003-06-10 Avecia Biotechnology Inc. Coupling reagent for h-phosphonate chemistry
CA2477039A1 (en) * 2002-02-22 2003-09-04 Honeywell International Inc. Methods of producing phosphitylated compounds
GB0209539D0 (en) * 2002-04-26 2002-06-05 Avecia Ltd Monomer Polymer and process
WO2005077966A1 (en) * 2004-02-10 2005-08-25 Isis Pharmaceuticals, Inc. Substituted pixyl protecting groups for oligonucleotide synthesis
SG171914A1 (en) 2008-12-02 2011-07-28 Chiralgen Ltd Method for the synthesis of phosphorus atom modified nucleic acids
US8272150B2 (en) * 2008-12-12 2012-09-25 Speedplay, Inc. Shoe sole mounting standard for bicycle cleat
WO2010072831A1 (en) 2008-12-23 2010-07-01 Girindus America, Inc Sulfurizing reagents and their use for oligonucleotides synthesis
EP2451461A4 (en) 2009-07-06 2013-05-29 Ontorii Inc NOVEL NUCLEIC ACID PRODRUGS AND METHOD OF USE THEREOF
KR20130029108A (ko) 2010-06-30 2013-03-21 기린두스 아메리카 인코포레이티드 올리고뉴클레오타이드 합성을 위한 n-thio 화합물의 새로운 사용 방법
DK2620428T3 (da) 2010-09-24 2019-07-01 Wave Life Sciences Ltd Asymmetrisk hjælpegruppe
US9605019B2 (en) 2011-07-19 2017-03-28 Wave Life Sciences Ltd. Methods for the synthesis of functionalized nucleic acids
WO2013017469A1 (en) 2011-07-29 2013-02-07 Girindus America, Inc. Sulfurization reagents on solid supports
DK2872485T3 (da) 2012-07-13 2021-03-08 Wave Life Sciences Ltd Asymmetrisk hjælpegruppe
CN112007045B (zh) 2012-07-13 2026-01-06 波涛生命科学有限公司 手性控制
JP6246121B2 (ja) 2012-07-13 2017-12-13 株式会社新日本科学 キラル核酸アジュバント
WO2014085471A1 (en) * 2012-11-28 2014-06-05 Prognosdx Health, Inc. Acid-activated compositions for the treatment of cancers, methods of their use and methods of their preparation
WO2015108048A1 (ja) 2014-01-15 2015-07-23 株式会社新日本科学 抗腫瘍作用を有するキラル核酸アジュバンド及び抗腫瘍剤
US10322173B2 (en) 2014-01-15 2019-06-18 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
EP3095461A4 (en) 2014-01-15 2017-08-23 Shin Nippon Biomedical Laboratories, Ltd. Chiral nucleic acid adjuvant having immunity induction activity, and immunity induction activator
KR102423317B1 (ko) 2014-01-16 2022-07-22 웨이브 라이프 사이언시스 리미티드 키랄 디자인
WO2018215049A1 (en) * 2017-05-23 2018-11-29 F. Hoffmann-La Roche Ag Process for galnac oligonucleotide conjugates

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3444300A (en) * 1964-05-05 1969-05-13 Chevron Res N-polyhaloalkylthio compounds as fungicidal agents
FR1519704A (fr) * 1967-02-14 1968-04-05 Roussel Uclaf Nouveaux composés dithiocarbamiques hétérocycliques et procédé de préparation
US3546185A (en) 1968-03-20 1970-12-08 Monsanto Co Inhibiting premature vulcanization of diene rubbers
US5149798A (en) * 1989-04-06 1992-09-22 Worcester Foundation For Experimental Biology Process for synthesizing oligonucleotides and their analogs adaptable to large scale syntheses
EP0678096B1 (en) * 1993-01-08 1997-03-19 HYBRIDON, Inc. Synthesis of dimmer blocks and their use in assembling oligonucleotides
GB9501465D0 (en) * 1995-01-25 1995-03-15 King S College London Nucleoside phosphorothioate derivatives,synthesis and use thereof
GB0004889D0 (en) * 2000-03-01 2000-04-19 Avecia Ltd Synthesis of oligonucleotides

Also Published As

Publication number Publication date
US20050240015A1 (en) 2005-10-27
DE69813243T2 (de) 2004-01-29
KR20010022840A (ko) 2001-03-26
HUP0002684A2 (hu) 2000-12-28
US7019127B2 (en) 2006-03-28
NO20000690D0 (no) 2000-02-11
TR200000384T2 (tr) 2000-11-21
PL338888A1 (en) 2000-11-20
EP1003758A2 (en) 2000-05-31
JP2001515086A (ja) 2001-09-18
EP1325927A2 (en) 2003-07-09
DK1003758T3 (da) 2003-07-21
IL134517A (en) 2004-02-19
BR9811166A (pt) 2000-07-25
US20030083490A1 (en) 2003-05-01
EP1003758B1 (en) 2003-04-09
CN1274361A (zh) 2000-11-22
EA003091B1 (ru) 2002-12-26
US6506894B1 (en) 2003-01-14
IN190784B (ref) 2003-08-23
GB9717158D0 (en) 1997-10-22
HUP0002684A3 (en) 2001-11-28
WO1999009041A3 (en) 1999-05-06
ES2197491T3 (es) 2004-01-01
CA2300874A1 (en) 1999-02-25
AU8738698A (en) 1999-03-08
NO20000690L (no) 2000-04-11
WO1999009041A2 (en) 1999-02-25
CN1231492C (zh) 2005-12-14
ATE236916T1 (de) 2003-04-15
DE69813243D1 (de) 2003-05-15
EP1325927A3 (en) 2008-07-02
IL134517A0 (en) 2001-04-30
EA200000211A1 (ru) 2000-08-28
AU749343B2 (en) 2002-06-27

Similar Documents

Publication Publication Date Title
IL134517A0 (en) Solution phase synthesis of oligonucleotides
IL151238A0 (en) Process for the preparation of phosphorothioate triesters
FI944523A7 (fi) Papilloomaviruksen inhibitio vastinjuosteoligonukleotidilla
DE69521517D1 (de) Prodrug-oligonukleotide
FI944568A0 (fi) Oligonukleotidien synteesi
FI924964A0 (fi) Modulering av genexpression genom stoerande inverkan pao sekundaerstrukturen hos rna
AU7621600A (en) Human rnase h and oligonucleotide compositions thereof
EP0521108A4 (en) Site specific cleavage of single-stranded dna
DE69703298D1 (de) Propargylethoxyamino nucleotide
WO1997006662A3 (en) Inverted chimeric and hybrid oligonucleotides
DE69319972D1 (de) Hyperthermophilische alpha-amylase Gene
ES2135094T3 (es) Agentes cosmeticos que contienen alquilglucamidas de acidos grasos y compuestos de silicona.
ZA987446B (en) Process for reducing total acid number of crude oil
EP1131332A4 (en) ANTISENSE MODULATION OF THE INHIBITOR KAPPA B KINASE-BETA EXPRESSION
EP1131107A4 (en) ANTISENSE MODULATION OF THE EXPRESSION OF INHIBITOR-KAPPA-B-KINASE-ALPHA
Guzaev et al. Novel non-nucleosidic building blocks for the preparation of multilabeled oligonucleotides
AU6522599A (en) Use of a self-cleaving rna motif to modulate gene expression
WO2000042987A8 (en) Targeted vesicular constructs for cytoprotection and treatment of h. pylori infections
TR200000196T2 (tr) Avermektin bileşiklerinin üretimi.
IT1299849B1 (it) Unita' per il trasferimento di prodotti.
ES2163001T3 (es) Nuevos derivados de borneol, procedimiento para su preparacion y su utilizacion farmaceutica.
Bevers et al. Critical Nature of a Specific Uridine O 2-Carbonyl for Cleavage by the Hammerhead Ribozyme
JPS6436690A (en) Alkyl or alkenyl succinate used as corrosion inhibitor for oxidized fuel
GOLDBERG OXIDATIVE DNA SUGAR DAMAGE BY TARGETED ΑΝΤΙΒΙΟTIC FREE RADICALS

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)
PSEA Patent sealed
RENW Renewal (renewal fees accepted)